New Delhi, April 30 (IANS) Benefits of the Covid-19 vaccine far outweigh the risks of extremely rare potential side effects, pharma giant AstraZeneca said on Tuesday.The company's response, in a statement to IA
New Delhi, April 30 (IANS) Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca’s Covid vaccine, and the benefits far outweigh the risks of the jab, said
London, September 9 (IANS) A third dose of vaccines against Covid-19 may not be needed for everyone in the UK and rushing into a nationwide rollout may put extra pressure on the country's already burdened N
London, February 7 (PTI): The COVID-19 vaccine developed by Oxford University and produced by AstraZeneca has shown efficacy against the UK variant of the coronavirus, according to an ongoing study by researche
London, February 3 (IANS): The Oxford-AstraZeneca's Covid-19 vaccine showed 76 per cent efficacy against symptomatic infection for three months after a single dose, with protection maintained to the second
New Delhi, Novèmber 28 (IANS): The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks.
Adar Poonawalla, Founder and CEO, SII s
Reuters
Drugmakers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway.
LONDON, November 23 (Reuters) - AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world's fight against the global pandemic a new weapon, cheaper to make, easier
LONDON, November 23 (Reuters): AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.
&q
LONDON, November 19 (Reuters): Results of late-stage trials of University of Oxford's COVID-19 vaccine candidate should definitely be known by Christmas, the chief investigator on the study said on Thu
LONDON, October 26 (Reuters): One of the world's leading COVID-19 experimental vaccines produces an immune response in both young and old adults, raising hopes of a path out of the gloom and economic d
London, October 4 (IANS): The COVID-19 vaccine developed by scientists at the Oxford University, which is advanced stages of the trial, could be rolled out in as little as three months in the UK, a report said.
New Delhi, September 12 (IANS): Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it
ZURICH, September 10 (Reuters): AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a "wake-up call" but should not discourage resear
MUMBAI, September10 (Reuters): Serum Institute of India has put on hold trials of AstraZeneca's potential COVID-19 vaccine in the country until the British drugmaker restarts them, the company said on
New Delhi, September 10 (ANI): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 o
ZURICH/FRANKFURT (Reuters): AstraZeneca should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker's chief executive Pascal Soriot sai
New York, September 1 (IANS): The Covid-19 vaccine candidate developed by Oxford University in partnership with the UK-based global biopharmaceutical company AstraZeneca has reached Phase-3 trial in the US.
BRUSSELS, August 27 (Reuters): The European Commission has made a 336 million euros ($396 million) downpayment to British drug maker AstraZeneca to secure at least 300 million doses of its potential COVID-
New Delhi, August 7 (PTI): Serum Institute of India on Friday said it has entered into a new partnership with international vaccine alliance Gavi and Bill & Melinda Gates Foundation to accelerate manufactur